Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 08, 2024 (filed on Apr 08, 2024)Insider Name:Clemmer James COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:10,000Price:$6.70
-
Feb 29, 2024 (filed on Mar 04, 2024)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,927Price:$4.67
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-667Price:$8.65
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Clemmer James COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,372Price:$8.65
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Helsel DaveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-365Price:$8.65
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Centea ScottOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-255Price:$8.65
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Piccinini LauraOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-413Price:$8.65
-
Jul 21, 2023 (filed on Jul 25, 2023)Insider Name:Campbell Chad ThomasOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-395Price:$8.65
-
Jul 20, 2023 (filed on Jul 25, 2023)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-717Price:$8.74
-
Jul 20, 2023 (filed on Jul 25, 2023)Insider Name:Clemmer James COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,982Price:$8.74
Filings by filing date
-
Apr 08, 2024 (filed on Apr 08, 2024)Insider Name:Clemmer James COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:10,000Price:$6.70
-
Feb 29, 2024 (filed on Mar 04, 2024)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,927Price:$4.67
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Performance RightNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-30,242Price:--
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-6,975Price:$8.92
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Trowbridge Stephen AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:19,354Price:--
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Helsel DaveOwnership Type:Direct OwnershipSecurities:Performance RightNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-15,081Price:--
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Helsel DaveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,477Price:$8.92
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Helsel DaveOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:9,650Price:--
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Centea ScottOwnership Type:Direct OwnershipSecurities:Performance RightNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-11,782Price:--
-
Jul 19, 2023 (filed on Sep 21, 2023)Insider Name:Centea ScottOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,716Price:$8.92
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 14 Plaza Dr LATHAM NY 12110-2166 |
Tel: | 1-518-7951408 |
Website: | https://www.angiodynamics.com |
IR: | See website |
Key People | ||
James C. Clemmer President, Chief Executive Officer, Director | Stephen A. Trowbridge Chief Financial Officer, Executive Vice President | Chad T. Campbell Senior Vice President, General Manager - Vascular Access and Oncology |
Scott Centea Senior Vice President, General Manager - Endovasular Therapies | Laura Piccinini Senior Vice President, General Manager - International |
Business Overview |
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others. |
Financial Overview |
For the nine months ended 29 February 2024, AngioDynamics, Inc. revenues decreased 6% to $232.9M. Net loss increased from $31M to $170.9M. Revenues reflect Med Device segment decrease of 12% to $155.9M, United States segment decrease of 8% to $190.7M. Higher net loss reflects Legal increase from $6.9M to $30.5M (expense), Research and development - Balancing val increase of 13% to $24.6M (expense). |
Employees: | 815 as of May 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $172.29M as of Feb 29, 2024 |
Annual revenue (TTM): | $324.01M as of Feb 29, 2024 |
EBITDA (TTM): | -$2.45M as of Feb 29, 2024 |
Net annual income (TTM): | -$192.37M as of Feb 29, 2024 |
Free cash flow (TTM): | -$23.46M as of Feb 29, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 40,054,533 as of Apr 8, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |